Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy.
Hila Ben-YehudaMichal AradJavier María Peralta RamosEfrat SharonGiulia CastellaniShir FerreraLiora CahalonSarah Phoebeluc ColaiutaTomer-Meir SalameMichal SchwartzPublished in: Molecular neurodegeneration (2021)
The CCR2/CCL2 axis is required to modify pathology using PD-L1 blockade in a mouse model of tauopathy. This modification involves, in addition to monocytes, the accumulation of FOXP3+ regulatory CD4+ T cells in the brain, and the T-cell chemoattractant, Cxcl12.